These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11410373)

  • 41. Conformational changes affect binding and catalysis by ester-hydrolysing antibodies.
    Lindner AB; Eshhar Z; Tawfik DS
    J Mol Biol; 1999 Jan; 285(1):421-30. PubMed ID: 9878416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catalytic antibodies hydrolysing organophosphorus esters.
    Brimfield AA; Lenz DE; Maxwell DM; Broomfield CA
    Chem Biol Interact; 1993 Jun; 87(1-3):95-102. PubMed ID: 8344006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.
    Zhou D; Xu L; Huang W; Tonn T
    Molecules; 2018 May; 23(6):. PubMed ID: 29857542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspects of antibody-catalyzed primary amide hydrolysis.
    Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT
    Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8.
    Hotta K; Lange H; Tantillo DJ; Houk KN; Hilvert D; Wilson IA
    J Mol Biol; 2000 Oct; 302(5):1213-25. PubMed ID: 11183784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural mechanism of the antigen recognition by the L1 cell adhesion molecule antibody A10-A3.
    Wei CH; Lee ES; Jeon JY; Heo YS; Kim SJ; Jeon YH; Kim KH; Hong HJ; Ryu SE
    FEBS Lett; 2011 Jan; 585(1):153-8. PubMed ID: 21094640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consequences of periodic α-to-β(3) residue replacement for immunological recognition of peptide epitopes.
    Cheloha RW; Sullivan JA; Wang T; Sand JM; Sidney J; Sette A; Cook ME; Suresh M; Gellman SH
    ACS Chem Biol; 2015 Mar; 10(3):844-54. PubMed ID: 25559929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling the binding sites of anti-hen egg white lysozyme antibodies HyHEL-8 and HyHEL-26: an insight into the molecular basis of antibody cross-reactivity and specificity.
    Mohan S; Sinha N; Smith-Gill SJ
    Biophys J; 2003 Nov; 85(5):3221-36. PubMed ID: 14581222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody.
    Murali R; Kieber-Emmons T
    J Mol Recognit; 1997; 10(6):269-76. PubMed ID: 9770651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective anion sensing by chiral macrocyclic receptors with multiple hydrogen-bonding sites.
    Ema T; Okuda K; Watanabe S; Yamasaki T; Minami T; Esipenko NA; Anzenbacher P
    Org Lett; 2014 Mar; 16(5):1302-5. PubMed ID: 24528472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advantages of two- or polyvalent binding of a receptor to the corresponding ligand in comparison to univalent binding].
    Bobrovnyk SA; Demchenko MA; Komysarenko SV
    Ukr Biokhim Zh (1999); 2011; 83(3):58-64. PubMed ID: 21888055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rigid macrocyclic triamides as anion receptors: anion-dependent binding stoichiometries and 1H chemical shift changes.
    Choi K; Hamilton AD
    J Am Chem Soc; 2003 Aug; 125(34):10241-9. PubMed ID: 12926947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A semisynthetic epitope for kinase substrates.
    Allen JJ; Li M; Brinkworth CS; Paulson JL; Wang D; Hübner A; Chou WH; Davis RJ; Burlingame AL; Messing RO; Katayama CD; Hedrick SM; Shokat KM
    Nat Methods; 2007 Jun; 4(6):511-6. PubMed ID: 17486086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition of peptides by antibodies and investigations of affinity using biosensor technology.
    Van Regenmortel MH; Choulier L
    Comb Chem High Throughput Screen; 2001 Aug; 4(5):385-95. PubMed ID: 11472227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A structurally based approach to determine HLA compatibility at the humoral immune level.
    Duquesnoy RJ
    Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.
    Tsuchiya Y; Mizuguchi K
    Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.
    Motté P; Alberici G; Ait-Abdellah M; Bellet D
    J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three-dimensional structure and antigen binding specificity of antibodies.
    Tello D; Spinelli S; Souchon H; Saul FA; Riottot MM; Mariuzza RA; Lascombe MB; Houdusse A; Eiselé JL; Fischmann T
    Biochimie; 1990 Aug; 72(8):507-12. PubMed ID: 1704260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.